Stereotaxis (NYSEAMERICAN:STXS) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Posted by Geri Gentry on May 12th, 2026

Stereotaxis (NYSEAMERICAN:STXS – Get Free Report) released its earnings results on Tuesday. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.01), FiscalAI reports. Stereotaxis had a negative net margin of 66.85% and a negative return on equity of 291.99%. The firm had revenue of $6.29 million during the quarter, compared to the consensus estimate of $8.50 million.

Stereotaxis Stock Up 2.1%

Shares of NYSEAMERICAN:STXS traded up $0.04 during midday trading on Tuesday, hitting $1.92. The stock had a trading volume of 348,143 shares, compared to its average volume of 473,082. Stereotaxis has a 12 month low of $1.74 and a 12 month high of $3.59. The business’s 50-day simple moving average is $1.93 and its 200-day simple moving average is $2.26. The company has a market cap of $187.16 million, a P/E ratio of -7.68 and a beta of 1.34.

Hedge Funds Weigh In On Stereotaxis

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Deutsche Bank AG grew its stake in shares of Stereotaxis by 10.6% in the fourth quarter. Deutsche Bank AG now owns 51,584 shares of the company’s stock valued at $119,000 after buying an additional 4,948 shares in the last quarter. Schonfeld Strategic Advisors LLC grew its stake in shares of Stereotaxis by 47.0% in the fourth quarter. Schonfeld Strategic Advisors LLC now owns 17,801 shares of the company’s stock valued at $41,000 after buying an additional 5,692 shares in the last quarter. BNP Paribas Financial Markets grew its stake in shares of Stereotaxis by 106.5% in the third quarter. BNP Paribas Financial Markets now owns 11,461 shares of the company’s stock valued at $36,000 after buying an additional 5,910 shares in the last quarter. Bank of America Corp DE grew its stake in shares of Stereotaxis by 12.0% in the third quarter. Bank of America Corp DE now owns 63,114 shares of the company’s stock valued at $196,000 after buying an additional 6,742 shares in the last quarter. Finally, Barclays PLC grew its stake in shares of Stereotaxis by 4.9% in the fourth quarter. Barclays PLC now owns 150,246 shares of the company’s stock valued at $346,000 after buying an additional 7,062 shares in the last quarter. 45.35% of the stock is owned by institutional investors.

Stereotaxis Company Profile

(Get Free Report)

Stereotaxis, Inc is a medical device company that develops and commercializes robotic magnetic navigation systems for use in electrophysiology procedures. Its core technology leverages precisely controlled magnetic fields to guide ultra-thin, magnetically enabled catheters through the vascular system, allowing physicians to perform complex cardiac ablation and diagnostic procedures with enhanced precision and stability. This platform aims to reduce procedure times and radiation exposure for both patients and clinical staff.

The company’s flagship offering, the Niobe Magnetic Navigation System, integrates with a variety of catheter types and electrophysiology mapping systems to support treatment of arrhythmias such as atrial fibrillation and ventricular tachycardia.